Thromboembolic and bleeding complications after elective cardioversion of atrial fibrillation: a nationwide cohort study.

Saga Itäinen-Strömberg Mika Lehto Olli Halminen Jukka Putaala Jari K Haukka Ossi Lehtonen Konsta Teppo Pirjo Mustonen Miika Linna Juha E K Hartikainen Kari Eino Juhani Airaksinen Aapo L Aro

Published in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2024)

The rate of thromboembolic and bleeding complications related to ECV was low without significant difference between NOAC- and warfarin-treated patients. With warfarin, INR ≥2.5 at the time of cardioversion reduced the risk of thromboembolic complications.

Keyphrases

atrial fibrillation
oral anticoagulants
direct oral anticoagulants
left atrial
catheter ablation
left atrial appendage
risk factors
heart failure
percutaneous coronary intervention
patients undergoing
venous thromboembolism